Cardiac Ablation (Catheter Ablation for Arrhythmias)

Candidacy depends on arrhythmia type. For SVT (AVNRT, WPW) and typical atrial flutter, ablation is recommended as first-line definitive therapy with >95% cure rates. For paroxysmal atrial fibrillation, the 2024 HRS guidelines now support ablation as first-line therapy (Class IIa) based on patient preference, in addition to the established indication after failed antiarrhythmic medication. For persistent AF, ablation is recommended after failed medication or for selected patients with heart failure. VT ablation is indicated after failed antiarrhythmic drugs, recurrent ICD shocks, or electrical storm. Your electrophysiologist will assess candidacy based on arrhythmia documentation, symptoms, and cardiac structure.

Thai cardiac centers offer radiofrequency ablation (RFA, the gold standard using resistive heating), cryoablation (freezing via cryoballoon, primarily for AF), and pulsed field ablation (PFA, the newest technology using irreversible electroporation). PFA is tissue-selective — it affects heart muscle cells while sparing the esophagus, phrenic nerve, and pulmonary veins from collateral damage. Bangkok Heart Hospital is currently the only confirmed PFA center in Thailand. All major centers use 3D electroanatomical mapping systems (CARTO 3 or EnSite X) for precise catheter navigation.

Published data shows single-procedure freedom from AF at 12 months of 60-80% for paroxysmal AF and 50-70% for persistent AF. With a repeat procedure (needed in 20-30% of paroxysmal and 30-40% of persistent AF patients), success rates improve to 75-90% and 60-80% respectively. Success depends on AF duration, left atrial size, and patient factors. For SVT and typical flutter, single-procedure cure rates exceed 95%. These figures represent freedom from arrhythmia recurrence after the 3-month blanking period, during which early recurrences are common and do not indicate procedural failure.

The blanking period is the first 3 months after AF ablation during which arrhythmia recurrences are expected and do NOT indicate procedure failure. During this time, ablation lesions are maturing into scar tissue and inflammation is resolving. Antiarrhythmic medications are typically continued through this period. Only arrhythmias occurring after 3 months are considered true recurrences. Monitoring with Holter or event monitors is initiated around the 3-month mark to assess ablation success.

Flight timing depends on procedure type. After SVT or flutter ablation, flying is generally safe after 5-7 days. After AF ablation, waiting 7-14 days is recommended to monitor for delayed complications such as cardiac tamponade. After VT ablation, a minimum 10-14 day wait is advised. For all long-haul flights, recommendations include compression stockings, adequate hydration, continuing anticoagulation, an aisle seat for periodic walking, and DVT prophylaxis for flights exceeding 4 hours. Your electrophysiologist will provide individualized fitness-to-fly clearance.

Thailand's all-inclusive cardiac ablation packages typically range from $3,800-$12,000 depending on arrhythmia type and energy modality, compared to estimated US hospital charges of $15,000-$60,000. SVT/flutter ablation costs $3,800-$6,000 (vs US $15,000-$30,000), AF ablation with RFA/cryo costs $7,000-$10,000 (vs US $30,000-$50,000), and AF ablation with PFA costs $9,000-$12,000 (vs US $40,000-$60,000). Estimated savings are 70-80%. Packages generally include pre-operative diagnostics, EP study, ablation procedure, 3D mapping, hospitalization, and follow-up. Actual costs depend on procedure complexity and individual factors.

Anticoagulation management after AF ablation follows strict guidelines. All patients continue anticoagulation for a minimum of 2-3 months regardless of apparent ablation success. The decision to discontinue thereafter is based on your CHA2DS2-VASc stroke risk score — NOT on whether the ablation was successful. Patients with scores of 2 or higher (men) or 3 or higher (women) require indefinite anticoagulation per 2024 HRS guidelines. Ablation reduces AF burden and symptoms but does not eliminate long-term stroke risk in high-risk patients.

Repeat ablation is a well-established and common practice, particularly for AF. Approximately 20-30% of paroxysmal AF patients and 30-40% of persistent AF patients undergo a second procedure within 2 years. Repeat procedures often target reconnected pulmonary veins or additional arrhythmia triggers identified during the first procedure. Success rates improve significantly with repeat ablation (75-90% for paroxysmal AF). For SVT, only 2-5% require a repeat procedure. If repeat ablation is needed during the same Thailand trip, additional costs and extended stay should be anticipated.

Recommended minimum stays depend on procedure type: 7-10 days for SVT/flutter ablation (short recovery, low complication risk), 14-21 days for AF ablation (longer monitoring needed, anticoagulation management), and 21-28 days for VT ablation (longest recovery, highest complication risk, need for stable rhythm confirmation). These timelines include pre-operative workup (2-3 days), the procedure itself, hospital recovery, and post-discharge monitoring before fitness-to-fly clearance.

Before departure, your Thai EP team will provide comprehensive documentation including ablation procedure reports, 3D mapping images, lesion set details, and a structured follow-up plan. This enables seamless handoff to your home cardiologist. Recommended monitoring includes Holter or event monitor at 3, 6, and 12 months to assess arrhythmia recurrence. Digital copies of all records are provided for cloud access. Telehealth follow-up with the Thai EP team can be arranged for ongoing coordination. For patients with ICDs, remote monitoring setup is confirmed before departure.